Vendor partnerships are one of the most underused growth levers in independent pharmacy. Done right, the right partnership opens up a new patient program, a new revenue line, or a new layer of clinical credibility. Done wrong, it drains attention and produces nothing.
This is the framework we use when evaluating partnership opportunities.
The four types of vendor partnerships
1. Manufacturer programs
A manufacturer offers your pharmacy an access program for a specific product line — patient assistance, branded program enrollment, manufacturer copay support. Examples: Lilly’s direct programs for GLP-1s, Pfizer’s patient access programs, manufacturer-direct programs for specialty meds.
What works: A focused program that you can integrate into existing workflow without rewiring operations. A weight-management partnership that funnels eligible patients into your GLP-1 service is a multiplier.
What doesn’t: Programs that require dedicated staff to administer and produce only marginal patient volume.
2. Wholesaler-driven services
Your primary or secondary wholesaler offers marketing support, branded patient programs, clinical service packages. McKesson Health Mart, Cardinal Health Leader, AmerisourceBergen Good Neighbor.
What works: Co-branded campaigns where the wholesaler provides creative and you provide the local context. Med sync programs, immunization clinics, OTC merchandising support.
What doesn’t: Generic branded marketing that doesn’t reflect your actual pharmacy identity.
3. Technology partnerships
Pharmacy systems, automation layers, telehealth platforms, clinical workflow tools. A good tech partnership reduces operational friction. A bad one adds three logins and no value.
What works: Technology that solves a specific operational problem your team currently spends time on (refill reminders, prior auth, e-prescribing fixes, MTM workflows).
What doesn’t: Generalized “growth platforms” that promise everything and deliver dashboards.
4. Clinical and data partnerships
Lab partners, point-of-care testing companies, clinical decision-support tools, real-world data programs. These let you offer clinical services patients otherwise have to leave your pharmacy to access.
What works: A POC testing partnership for strep, flu, COVID, or a lab partnership for hormone testing that feeds into your BHRT consultations. New revenue, captive patient flow.
What doesn’t: Data partnerships that require your patient data but offer no patient-facing benefit.
Five questions to ask any vendor before signing
- What specific patient problem does this solve in my workflow?
- How many hours per week does my team need to spend administering it?
- What’s the revenue per patient enrolled, after manufacturer fees and your costs?
- Who is the named relationship owner on the vendor’s side after onboarding?
- What does success look like at 90 days and what happens if we don’t hit it?
The signals of a partnership that will pay off
- Vendor brings specific patient acquisition assistance (not just access to the product)
- Clear measurement around enrollments, adherence, and revenue
- Named, accessible relationship owner
- Marketing support that you can actually use (not generic stock graphics)
- Quarterly business reviews built into the contract
The signals of a partnership that will drain you
- Vendor needs you to fund the marketing for a product you’re not buying at scale
- Vague “partnership” framing with no specific patient program attached
- Required exclusivity that locks out other vendors
- No clear measurement framework
- Onboarding goes to “support” instead of a named account manager
How to structure your vendor portfolio
For most independent pharmacies, the right mix is:
- Primary wholesaler (1)
- Secondary wholesaler (1, for shortages and specialty access)
- 2-3 manufacturer programs aligned to your top patient populations
- 1 technology partnership for automation/refill workflow
- 1-2 clinical service partnerships (POC testing, lab, telehealth)
More than that and you spend the day managing vendors instead of running the pharmacy.
FAQ
Are vendor “marketing fees” worth it?
Only when the marketing assets they produce are usable in your local market. Generic national-level creative usually isn’t. Custom local creative often is.
How do we negotiate with wholesalers on partnership programs?
Ask for measurement and named-owner commitments before agreeing to volume targets. A program with no measurement is a program that fails quietly.
What about non-traditional partners (telehealth, weight loss platforms)?
Evaluate them the same way. The question is always: does this drive specific patients to my counter that I wouldn’t otherwise see?
Want help vetting a vendor partnership? Get in touch — we evaluate partnerships for pharmacies in our network regularly.